These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29956532)

  • 1. [Not Available].
    Krieg B
    Med Monatsschr Pharm; 2016 Nov; 39(11):497-8. PubMed ID: 29956532
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful transition to buprenorphine in a patient with methadone-induced torsades de pointes.
    Esses JL; Rosman J; Do LT; Schweitzer P; Hanon S
    J Interv Card Electrophysiol; 2008 Nov; 23(2):117-9. PubMed ID: 18686025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Torsades de pointes with methadone treatment].
    Auguet-Mancini P; Guyomar Y; Cordova H; Urso-Baiardo L
    Presse Med; 2012 Jan; 41(1):90-5. PubMed ID: 21549554
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of methadone-induced torsades de pointes with lidocaine.
    Rajpal S; Mundi AS; Reddy PC; Akkus NI
    J La State Med Soc; 2013; 165(6):338-41. PubMed ID: 25073261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Torsades de pointes with methadone.
    Prescrire Int; 2005 Apr; 14(76):61-2. PubMed ID: 15875343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenytoin in Treatment of Methadone-Induced Torsades de Pointes: A Case Report.
    Altheeb Z; Alziadat M; Shamoon F
    Am J Ther; 2017; 24(5):e634-e636. PubMed ID: 27754988
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular-associated disease in an addicted population: an observation study.
    Demarie D; Marletta G; Imazio M; Cappa C; Ferro S; Compostino R; De Vivo E; Trinchero R; Bignamini E
    J Cardiovasc Med (Hagerstown); 2011 Jan; 12(1):51-4. PubMed ID: 21135593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained release oral morphine as an alternative to methadone for the treatment of opioid-use disorder post Torsades de Pointes cardiac arrest.
    Walton G; Nolan S; Sutherland C; Ahamad K
    BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26392442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buprenorphine-based regimens and methadone for the medical management of opioid dependence: selecting the appropriate drug for treatment.
    Maremmani I; Gerra G
    Am J Addict; 2010; 19(6):557-68. PubMed ID: 20958853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First, do no harm: QT interval screening in methadone maintenance treatment.
    Haigney MC
    J Addict Dis; 2011 Oct; 30(4):309-12. PubMed ID: 22026521
    [No Abstract]   [Full Text] [Related]  

  • 11. Ciprofloxacin-induced torsades de pointes in a methadone-dependent patient.
    Nair MK; Patel K; Starer PJ
    Addiction; 2008 Dec; 103(12):2062-4. PubMed ID: 19469750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QT or not QT, that is the question: routine electrocardiograms for individuals in methadone maintenance treatment.
    Stimmel B
    J Addict Dis; 2011 Oct; 30(4):307-8. PubMed ID: 22026520
    [No Abstract]   [Full Text] [Related]  

  • 13. CSAT's QT interval screening in methadone report: outrageous fortune or sea of troubles?
    Bart G
    J Addict Dis; 2011 Oct; 30(4):313-7. PubMed ID: 22026522
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of opioid substitution therapy during medical intervention.
    Murnion B
    Intern Med J; 2012 Mar; 42(3):242-6. PubMed ID: 22432983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity.
    Toce MS; Chai PR; Burns MM; Boyer EW
    J Med Toxicol; 2018 Dec; 14(4):306-322. PubMed ID: 30377951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of buprenorphine on cardiac repolarization in a patient with methadone-related torsade de pointes.
    Krantz MJ; Garcia JA; Mehler PS
    Pharmacotherapy; 2005 Apr; 25(4):611-4. PubMed ID: 15977920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrected QT interval during treatment with methadone and buprenorphine--relation to doses and serum concentrations.
    Stallvik M; Nordstrand B; Kristensen Ø; Bathen J; Skogvoll E; Spigset O
    Drug Alcohol Depend; 2013 Apr; 129(1-2):88-93. PubMed ID: 23084592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When a seizure is not a real seizure!
    Talebi S; Ghobadi F; Chaudhari S; Gracia E; Olatunde O; Pekler G; Visco F; Hassen GW
    Am J Emerg Med; 2016 Apr; 34(4):757.e3-5. PubMed ID: 26409502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Should I stay or should I go?" Coming off methadone and buprenorphine treatment.
    Winstock AR; Lintzeris N; Lea T
    Int J Drug Policy; 2011 Jan; 22(1):77-81. PubMed ID: 20956077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of QTc interval prolongation for patients in methadone versus buprenorphine maintenance treatment: a 5-year follow-up.
    Fareed A; Patil D; Scheinberg K; Blackinton Gale R; Vayalapalli S; Casarella J; Drexler K
    J Addict Dis; 2013; 32(3):244-51. PubMed ID: 24074190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.